202 related articles for article (PubMed ID: 8384980)
1. Treatment of chronic hepatitis C with high-dose interferon alpha-2b. A multicenter study.
Iino S; Hino K; Kuroki T; Suzuki H; Yamamoto S
Dig Dis Sci; 1993 Apr; 38(4):612-8. PubMed ID: 8384980
[TBL] [Abstract][Full Text] [Related]
2. Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc).
Payen JL; Izopet J; Galindo-Migeot V; Lauwers-Cances V; Zarski JP; Seigneurin JM; Dussaix E; Voigt JJ; Selves J; Barange K; Puel J; Pascal JP
Hepatology; 1998 Dec; 28(6):1680-6. PubMed ID: 9828235
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of recombinant alpha-2a-interferon for chronic hepatitis C. Comparison of alanine aminotransferase normalization versus loss of HCV RNA and anti-HCV IgM.
Douglas DD; Rakela J; Lin HJ; Hollinger FB; Taswell HF; Czaja AJ; Gross JB; Anderson ML; Parent K; Fleming CR
Dig Dis Sci; 1993 Apr; 38(4):601-7. PubMed ID: 8384978
[TBL] [Abstract][Full Text] [Related]
4. Treatment of chronic hepatitis C by continuous subcutaneous infusion of interferon-alpha.
Carreño V; Tapia L; Ryff JC; Quiroga JA; Castillo I
J Med Virol; 1992 Jul; 37(3):215-9. PubMed ID: 1331310
[TBL] [Abstract][Full Text] [Related]
5. Changes in serum hepatitis C virus RNA titer and response to interferon therapy in patients with chronic hepatitis C.
Aiyama T; Yoshioka K; Hirofuji H; Kusakabe A; Yamada M; Tanaka K; Kakumu S
Dig Dis Sci; 1994 Oct; 39(10):2244-9. PubMed ID: 7924750
[TBL] [Abstract][Full Text] [Related]
6. Dose increase augments response rate to interferon-alpha in chronic hepatitis C.
Ferenci P; Stauber R; Propst A; Fiedler R; Müller C; Gschwantler M; Schütze K; Datz C; Judmaier G; Vogel W; Krejs GJ; Gangl A
Dig Dis Sci; 1996 Dec; 41(12 Suppl):103S-108S. PubMed ID: 9011466
[TBL] [Abstract][Full Text] [Related]
7. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
Farrell GC; Bacon BR; Goldin RD
Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
[TBL] [Abstract][Full Text] [Related]
8. The role of alpha-glutathione S-transferase in the monitoring of hemodialysis patients with hepatitis C virus infection undergoing high-dose interferon-alpha-2b therapy.
Boran M; Cetin S
Nephron; 1999; 82(1):22-6. PubMed ID: 10224480
[TBL] [Abstract][Full Text] [Related]
9. Comparison of high initial and fixed-dose regimens of interferon-alpha2a in chronic hepatitis C: a randomized controlled trial. French Multicenter Interferon Study Group.
Ouzan D; Babany G; Valla D; Opolon P
J Viral Hepat; 1998 Jan; 5(1):53-9. PubMed ID: 9493517
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype 1b and high virus load.
Arase Y; Ikeda K; Tsubota A; Suzuki Y; Saitoh S; Kobayashi M; Kobayashi M; Suzuki F; Akuta N; Someya T; Kumada H
J Gastroenterol; 2003; 38(2):158-63. PubMed ID: 12640530
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent and genotype-independent sustained virological response of a 12 week pegylated interferon alpha-2b treatment for acute hepatitis C.
De Rosa FG; Bargiacchi O; Audagnotto S; Garazzino S; Cariti G; Raiteri R; Di Perri G
J Antimicrob Chemother; 2006 Feb; 57(2):360-3. PubMed ID: 16396921
[TBL] [Abstract][Full Text] [Related]
12. High dose interferon treatment in chronic hepatitis C.
Iino S
Gut; 1993; 34(2 Suppl):S114-8. PubMed ID: 8314475
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. The TriVeneto Viral Hepatitis Group.
Chemello L; Bonetti P; Cavalletto L; Talato F; Donadon V; Casarin P; Belussi F; Frezza M; Noventa F; Pontisso P
Hepatology; 1995 Sep; 22(3):700-6. PubMed ID: 7657272
[TBL] [Abstract][Full Text] [Related]
14. Two dose regimens of recombinant interferon-alpha-2b in chronic hepatitis C virus infection. Biochemistry, hepatitis C virus RNA, and liver histology as response indices.
Bjøro K; Krarup H; Bell H; Christophersen P; Evensen S; Frøland SS; Laursen A; B vd Lippe B; Maeland A; Ranek L
Scand J Gastroenterol; 1995 Nov; 30(11):1119-24. PubMed ID: 8578174
[TBL] [Abstract][Full Text] [Related]
15. Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: a randomized multicenter trial. Hepatitis Interventional Therapy Group.
Lindsay KL; Davis GL; Schiff ER; Bodenheimer HC; Balart LA; Dienstag JL; Perrillo RP; Tamburro CH; Goff JS; Everson GT; Silva M; Katkov WN; Goodman Z; Lau JY; Maertens G; Gogate J; Sanghvi B; Albrecht J
Hepatology; 1996 Nov; 24(5):1034-40. PubMed ID: 8903371
[TBL] [Abstract][Full Text] [Related]
16. Lack of benefit of escalating dosage of interferon alfa in patients with chronic hepatitis C.
Marcellin P; Pouteau M; Martinot-Peignoux M; Degos F; Duchatelle V; Boyer N; Lemonnier C; Degott C; Erlinger S; Benhamou JP
Gastroenterology; 1995 Jul; 109(1):156-65. PubMed ID: 7540996
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment.
Campistol JM; Esforzado N; Martínez J; Roselló L; Veciana L; Modol J; Casellas J; Pons M; de Las Cuevas X; Piera J; Oliva JA; Costa J; Barrera JM; Bruguera M
Nephrol Dial Transplant; 1999 Nov; 14(11):2704-9. PubMed ID: 10534516
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha therapy for hepatitis C virus infection after liver transplantation.
Wright TL; Combs C; Kim M; Ferrell L; Bacchetti P; Ascher N; Roberts J; Wilber J; Sheridan P; Urdea M
Hepatology; 1994 Oct; 20(4 Pt 1):773-9. PubMed ID: 7927216
[TBL] [Abstract][Full Text] [Related]
19. Alanine aminotransferase and HCV-RNA responses following interferon therapy of HCV-RNA positive chronic hepatitis.
Arase Y; Kumada H; Chayama K; Tsubota A; Ikeda K; Saitoh S; Sakai Y; Matsumoto T; Kobayashi M
Gastroenterol Jpn; 1992 Oct; 27(5):646-51. PubMed ID: 1330798
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group.
Tong MJ; Reddy KR; Lee WM; Pockros PJ; Hoefs JC; Keeffe EB; Hollinger FB; Hathcote EJ; White H; Foust RT; Jensen DM; Krawitt EL; Fromm H; Black M; Blatt LM; Klein M; Lubina J
Hepatology; 1997 Sep; 26(3):747-54. PubMed ID: 9303508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
